The reno-protective effect of metformin against type 2 diabetic rats via up-regulating renal tissue pigment epithelium-derived factor expression
Background. Diabetic nephropathy has become the primary cause of end-stage renal disease worldwide. Pigment epithelium-derived factor (PEDF) is an endogenous anti-inflammatory factor in vivo, which can inhibit the expression of pathogenic factors — transforming growth factor β1 and connective tissue...
Main Authors: | Liu Jiarui, Bi Shuangjie, Ye Shandong |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2019-11-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Subjects: | |
Online Access: | http://iej.zaslavsky.com.ua/article/view/191680 |
Similar Items
-
Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial
by: Rebecca M. Reynolds, et al.
Published: (2017-09-01) -
Determination of structural properties in the adsorption of drugs on chitosan-hydrogels for type 2 diabetes by means of the PM6 method
by: Nancy Liliana Delgadillo Armendariz, et al.
Published: (2020-05-01) -
Comparison of Antioxidant Effects of Honey, Glibenclamide, Metformin, and Their Combinations in the Kidneys of Streptozotocin-Induced Diabetic Rats
by: Mohd Suhaimi Ab Wahab, et al.
Published: (2011-01-01) -
Potential therapeutic effects of pigment epithelium-derived factor for treatment of diabetic retinopathy
by: Xiao Liu, et al.
Published: (2013-04-01) -
Effect of local injection of pigment epithelium-derived factor on angiogenesis, inflammatory response and apoptosis in the retina of diabetic rats
by: Hong-Lan Yang, et al.
Published: (2018-08-01)